Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000242505

Medchemexpress LLC Pyrrolo[3,4-b]pyrrole-5(1H)-carboxamide, N-[4-(3-ethynylphenyl)amino-7-methoxy-6-quinazolinyl]hex... | 1353644-70-8 | MFCD00038264 | 99.7% | 442.51 g/mol | C25H26N6O2 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY104066100MG

Encompass_Preferred

Theliatinib is a potent, ATP-competitive, orally active, and highly selective epidermal growth factor receptor (EGFR) inhibitor provided for research use. It shows low nanomolar cellular activity against EGFR and has been evaluated in preclinical models of EGFR-driven cancers.

  • Potent EGFR inhibition (Ki ≈ 0.05 nM; IC50 ≈ 3 nM).
  • Highly selective for EGFR over common off-target kinases.
  • Suitable for in vitro and in vivo preclinical studies.
  • High reported purity for reliable assay results.
  • Formulation as a solid; soluble in DMSO for assay preparation.

Catalog No. 50-002-42505


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.